Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Translating the DPP Into the Community: The YMCA Model
This study is ongoing, but not recruiting participants.
Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier: NCT00302042
  Purpose

The Diabetes Prevention Program (DPP) demonstrated that an intensive lifestyle intervention resulting in modest weight loss and increased physical activity can delay or prevent the development of type 2 diabetes in those at increased risk for the disease. The lifestyle program used, however, was not designed for delivery on a public health scale. Successful community translation of the DPP's findings will require close collaboration with an established community organization committed to improving community health and experienced in implementing sustainable health and wellness programs. With exceptional reach into diverse U.S. communities, the YMCA may be an ideal community partner. We have been collaborating with the YMCA organization for over a year to design a robust recruitment and implementation model that is sensitive to the unique needs and resources of a community organization. We now propose to evaluate if a group-based adaptation of the DPP lifestyle intervention can be successfully implemented by YMCA staff, in YMCA facilities. We have designed this study to develop preliminary data about the reach, effectiveness, and consistent implementation of the DPP lifestyle intervention in this context. This pilot study has two primary aims: 1) to demonstrate the extent to which YMCA staff trained by DPP study personnel can administer a group-based adaptation of the DPP lifestyle intervention in a fashion consistent with DPP intervention protocols, and 2) to evaluate if the intervention program delivered by the YMCA results in changes in body mass, physical activity, and dietary intake that are consistent with a level found to be associated with diabetes risk reduction during the DPP trial. We will also collect valuable data about the feasibility and reach of a selective, community-based marketing and screening approach for recruiting program participants. In combination, these data will enable us to design and conduct a larger, future 3-year trial focusing on the effectiveness and sustainability of community DPP translation in multiple YMCA settings.


Condition Intervention Phase
Prediabetic State
Overweight
Obesity
Behavioral: Pre-diabetes assessment and general advice about lifestyle based strategies to prevent type 2 diabetes
Behavioral: Pre-diabetes assessment, brief advice, and access to a group-based diabetes prevention lifestyle intervention at the YMCA
Phase II

MedlinePlus related topics: Diabetes Obesity Weight Control
Drug Information available for: BaseLine
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Placebo Control, Single Group Assignment, Safety/Efficacy Study
Official Title: Translating the DPP Into the Community: The YMCA Model

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Primary Outcome Measures:
  • Weight loss [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Physical activity level [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Rate of community program participation [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Change in dietary composition [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Enrollment: 92
Study Start Date: May 2005
Estimated Study Completion Date: May 2008
Estimated Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Brief counseling for pre-diabetes plus access to a group-based diabetes prevention lifestyle intervention at the YMCA
Behavioral: Pre-diabetes assessment, brief advice, and access to a group-based diabetes prevention lifestyle intervention at the YMCA
Pre-diabetes risk assessment, education, and counseling offered at baseline, 6, 12-months. 16-visit lifestyle intervention program occuring for 1 hour every 7-10 days for first 5 months, followed by monthly 90 minute maintenance meetings at YMCA
2: Active Comparator
Brief Counseling for pre-diabetes alone
Behavioral: Pre-diabetes assessment and general advice about lifestyle based strategies to prevent type 2 diabetes
Pre-diabetes risk assessment with brief education and counseling performed by School of Medicine partners at the YMCA and repeated after 6 and 12 months

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

i. 18 years of age or older ii. Body-mass index of >= 24 kg/m2 iii. ADA diabetes risk assessment score >= 10 (see below) iv. Casual capillary blood glucose >= 110 mg/dl

Exclusion Criteria:

i. Exclusions for diseases likely to limit life span and/or increase risk of interventions:

A. Cancer requiring treatment in the past 5 years

B. Cardiovascular disease:

  1. A "Yes" response to any item on the modified Physical Activity Readiness Questionnaire (see Appendix 2)
  2. Uncontrolled hypertension: SBP >180 mmHg or DBP >105 mmHg
  3. Heart attack, stroke, or transient ischemic attack in the past 6 months, C. Lung disease: Chronic obstructive airways disease or asthma requiring home oxygen

ii. Exclusions related to metabolism: A. Diabetes at baseline evaluation B. Casual capillary blood glucose >= 200 mg/dl C. History of anti-diabetic medication use (oral agents or insulin) except during gestational diabetes

D. Pregnant female E. Self-report of disease associated with disordered glucose metabolism: Cushing's syndrome; acromegaly; pheochromocytoma; chronic pancreatitis

iii. Exclusion for conditions or behaviors likely to affect the conduct of the study:

A. Unable or unwilling to provide informed consent B. Unable to communicate with the pertinent clinic staff C. Unable to read written English

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00302042

Locations
United States, Indiana
Indiana University Diabetes Prevention and Control Center
Indianapolis, Indiana, United States, 46202
Sponsors and Collaborators
Investigators
Principal Investigator: Ronald T Ackermann, MD, MPH Indiana University School of Medicine
  More Information

Responsible Party: Indiana University School of Medicine ( Ronald T. Ackermann, MD, MPH )
Study ID Numbers: DK70702, DK70702
Study First Received: March 10, 2006
Last Updated: January 3, 2008
ClinicalTrials.gov Identifier: NCT00302042  
Health Authority: United States: Institutional Review Board;   United States: Federal Government

Study placed in the following topic categories:
Obesity
Metabolic Diseases
Prediabetic State
Diabetes Mellitus
Endocrine System Diseases
Overweight
Body Weight
Signs and Symptoms
Nutrition Disorders
Overnutrition
Endocrinopathy
Glucose Metabolism Disorders
Metabolic disorder

ClinicalTrials.gov processed this record on January 16, 2009